The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Syria, World Bank negotiate partnership
- Brazil–Sudan: A Global South partnership
- UAE leads poultry imports from Brazil
- Triz publishing group opens unit in Sharjah
- Kuwait’s KUFPEC joins Santos Basin project
- Brazil expects record coffee harvest in 2026
- Brazil govt roadshows Riogaleão for stakeholders
- Brazilian teacher wins award in UAE
